| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 54081 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 75615 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 82244 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 118588 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 126684 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 139933 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 142025 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 149398 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 268496 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 368922 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 420048 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 420900 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 423320 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 472751 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 488217 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 520900 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 522953 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 527074 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 529225 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 564834 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 606314 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 614726 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 649642 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 673083 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 774491 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 847775 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 1045925 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (17:0) [Margaric acid) | 1046648 | Peak height | LGG Treated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|